Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X8QP
|
|||
Former ID |
DIB001247
|
|||
Drug Name |
FOSOPAMINE
|
|||
Synonyms |
S-2055; SIM-2055; Fosopamine; N-Methyldopamine 4-O-phosphate; 4-[2-(Methylamino)ethyl]-1,2-benzenediol 1-(dihydrogen phosphate)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Discontinued in Phase 2 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C9H14NO5P
|
|||
Canonical SMILES |
CNCCC1=CC(=C(C=C1)OP(=O)(O)O)O
|
|||
InChI |
1S/C9H14NO5P/c1-10-5-4-7-2-3-9(8(11)6-7)15-16(12,13)14/h2-3,6,10-11H,4-5H2,1H3,(H2,12,13,14)
|
|||
InChIKey |
WHEGQKBWPSOMHG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 103878-96-2
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002585) | |||
REF 2 | Development of dopaminergic drugs for the chronic treatment of congestive heart failure. J Auton Pharmacol. 1990;10 Suppl 1:s85-93. | |||
REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.